Argus analyst David Toung raised the firm’s price target on Labcorp (LH) to $290 from $260 and keeps a Buy rating on the shares after its Q4 ...
Discover how FTRE's $7.7B backlog, CRO market growth, and focus on high-margin areas ensure long-term growth, efficiency, and ...
Texas doctors said there's no harm in getting another measles vaccine if you don't know whether you were vaccinated as a ...
2d
Zacks Investment Research on MSNShould Labcorp Stock Stay in Your Portfolio Right Now?Labcorp Holdings Inc. LH, or Labcorp, is prioritizing key specialty testing areas, such as oncology, women’s health, autoimmune disease and neurology, aiming to tap into strong growth opportunities.
Labcorp has been a great trade, beating the S&P 500 by 6.9%. Its stock price has climbed to $255.01, representing a healthy ...
3d
Asianet Newsable on MSNLabcorp Gains Citi Upgrade While Quest Diagnostics Faces Downgrade On Margin Concerns — Retail Sentiment MixedA Wall Street analyst issued contrasting ratings on Tuesday for two major diagnostic testing companies, upgrading shares of ...
Shares of Labcorp Holdings Inc. LH rose 1.09% to $256.81 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index SPX falling 1.22% to 5,778.15 ...
A vehicle crashed into the LabCorp business at 595 Loudon Rd in Newton Plaza II on March 4, causing significant damage to the ...
Charles River Labs (CRL) stock and LabCorp (LH) stock were upgraded and Quest Diagnostics (DGX) stock was downgraded at Citi.
Senator Addabbo is teaming up with the NYC Taxi and Limousine Commission (TLC) to host a valuable resource event for ...
Citi upgraded Labcorp (LH) to Buy from Neutral with a price target of $300, up from $250. Utilization rates have been running high ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results